Bristol-Myers Squibb Co. (BMY) Misses Q4 EPS by 2c, Sales Fall Just Short
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $57.13 +0.40%
Revenue Growth %: -4.6%
Financial Fact:
Net Earnings Attributable to Bristol-Myers Squibb Company: 1.2B
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: -4.6%
Financial Fact:
Net Earnings Attributable to Bristol-Myers Squibb Company: 1.2B
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Bristol-Myers Squibb Co. (NYSE: BMY) reported Q4 EPS of $0.53, $0.02 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $5.45 billion versus the consensus estimate of $5.5 billion.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
- Bristol-Myers Squibb (BMY) call put ratio 6.8 calls to 1 put with a focus on spreader of 8244 contracts of June and July 57.50 calls
- Aspire Biopharma to acquire automotive supplier for $30 million
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
